ARA-290
Third-Party Tested · COA AvailableARA-290 (cibinetide) is an 11-amino-acid peptide derived from the helix-B domain of erythropoietin, studied for innate-repair-receptor signaling.
- Certificate of Analysis available for every lot
- ≥99% purity, HPLC & mass-spec verified
- Ships from a U.S. facility — same-day before 12pm CT
- Secure checkout · Free shipping on orders $300+
Innate Repair Receptor Peptide for Research
Technical Overview
ARA-290 (cibinetide) is an eleven-amino-acid peptide derived from the helix-B domain of erythropoietin. It is studied in laboratory models for innate-repair-receptor signaling pathways, notably without the erythropoietic activity of the parent molecule. Produced by solid-phase peptide synthesis and purified by HPLC.
Specifications
Purity: ≥ 99% (HPLC Verified)
Strength: 10 mg
Appearance: Lyophilized Powder
Format: Research Compound
Storage: Store at −20°C.
Research Disclaimer
Provided strictly as a chemical reagent for laboratory investigation. Not for human or veterinary use of any kind.
Certificate of Analysis & Safety Data
Frequently Asked Questions
Is ARA-290 third-party tested?
Yes. Every lot is independently third-party tested for identity and purity — ≥99% by HPLC and mass spectrometry — with a lot-matched Certificate of Analysis available to download on this page.
Can I see the Certificate of Analysis before buying?
Yes. A lot-matched COA is available on this product page and in our COA library before purchase, documenting identity, purity, and full analytical results.
What does 'Research Use Only' mean?
This product is supplied strictly for laboratory and research use only (RUO). It is not a drug, food, supplement, or cosmetic, is not approved by the FDA, and is not intended to diagnose, treat, cure, or prevent any disease, or for human or veterinary consumption.
How is it shipped and stored?
Orders placed before 12pm CT typically ship the same business day from our U.S. facility with tracking. Store the lyophilized material at −20°C, protected from light and moisture.
